Literature DB >> 11782021

Induction of arthritis and uveitis in Lewis rats by antigenic mimicry of peptides from HLA-B27 and cytokeratin.

Gerhild Wildner1, Maria Diedrichs-Möhring, Stephan R Thurau.   

Abstract

Ankylosing spondylitis (AS) is highly associated with HLA-B27. We have previously shown that peripheral blood lymphocytes from AS patients respond to stimulation with a peptide from the sequence of HLA-B27. Here we report on molecular mimicry of peptides from HLA-B27 and cytokeratin, the latter being specifically expressed in synovial membranes and eyes, the main targets of the autoaggressive immune response in AS patients. Immunization of rats with these peptides induced an inflammatory response in joints, spine and eyes, resembling the symptoms in AS. Furthermore, both HLA-B27- and cytokeratin-derived peptides, are effective oral tolerogens: feeding these peptides ameliorated arthritis and uveitis induced with the cytokeratin peptide. Our model might elucidate the role of peptides from the sequence of HLA-B27 as an antigen of the immune response in AS, introducing a new aspect of antigenic mimicry between HLA-B27 and tissue-specific antigens. We propose this as a mechanism directing a systemic autoimmune response to specific target organs by antigenic mimicry of T cell epitopes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11782021     DOI: 10.1002/1521-4141(200201)32:1<299::AID-IMMU299>3.0.CO;2-Q

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

Review 1.  Anti-inflammatory treatment of uveitis with biologicals: new treatment options that reflect pathogenetic knowledge of the disease.

Authors:  Arnd Heiligenhaus; Stephan Thurau; Maren Hennig; Rafael S Grajewski; Gerhild Wildner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-08-25       Impact factor: 3.117

Review 2.  A look at autoimmunity and inflammation in the eye.

Authors:  Rachel R Caspi
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

3.  Clinical patterns and characteristics of ankylosing spondylitis in China.

Authors:  Qiaoxia Qian; Xia Xu; Hongjun He; Hengdong Ji; Hui Zhang; Yue Ding; Sheng-Ming Dai; Yaohong Zou; Qi Zhu; Chengde Yang; Shuang Ye; Lindi Jiang; Jian-Ping Tang; Qiang Tong; Dongyi He; Dongbao Zhao; Yuan Li; Yanyun Ma; Jingru Zhou; Ziyu Yuan; Juan Zhang; Li Jin; Xiaodong Zhou; John D Reveille; Hejian Zou; Jiucun Wang
Journal:  Clin Rheumatol       Date:  2017-05-27       Impact factor: 2.980

4.  Multiple autoantigen mimotopes of infectious agents induce autoimmune arthritis and uveitis in lewis rats.

Authors:  Gerhild Wildner; Maria Diedrichs-Moehring
Journal:  Clin Diagn Lab Immunol       Date:  2005-05

5.  HLA-B27-restricted T cells from patients with ankylosing spondylitis recognize peptides from B*2705 that are similar to bacteria-derived peptides.

Authors:  E Frauendorf; H von Goessel; E May; E Märker-Hermann
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

6.  Cross-reaction between tyrosinase peptides and cytomegalovirus antigen by T cells from patients with Vogt-Koyanagi-Harada disease.

Authors:  Sunao Sugita; Hiroshi Takase; Tatsushi Kawaguchi; Chikako Taguchi; Manabu Mochizuki
Journal:  Int Ophthalmol       Date:  2007-01-26       Impact factor: 2.029

7.  Keratin 8 is a potential self-antigen in the coronary artery disease immunopeptidome: A translational approach.

Authors:  Peter M Mihailovic; Wai Man Lio; Romana Herscovici; Kuang-Yuh Chyu; Juliana Yano; Xiaoning Zhao; Jianchang Zhou; Bo Zhou; Michael R Freeman; Wei Yang; Prediman K Shah; Bojan Cercek; Paul C Dimayuga
Journal:  PLoS One       Date:  2019-02-27       Impact factor: 3.240

8.  Proliferative vitreoretinopathy may be a risk factor in combined macular hole retinal detachment cases.

Authors:  Matthew A Cunningham; Ryan M Tarantola; James C Folk; Elliott H Sohn; H Culver Boldt; Jordan A Graff; Korianne Elkins; Stephen R Russell; Vinit B Mahajan
Journal:  Retina       Date:  2013-03       Impact factor: 4.256

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.